Seed Innovations Limited (LSE:SEED) has revealed that its portfolio company, Little Green Pharma Ltd (LGP), delivered impressive financial results in its recent quarterly update. LGP recorded a record A$12.0 million in cash receipts alongside a positive net operating cash inflow of A$0.5 million, reflecting solid financial stability and promising growth momentum. The company experienced notable sales gains in key overseas markets, including a 70% increase in Danish facility shipments to Germany and over A$2.0 million worth of new orders from the UK.
These strong operational outcomes are expected to bolster LGP’s strategic expansion and contribute positively to Seed Innovations’ broader investment portfolio.
About Seed Innovations Limited
Seed Innovations Ltd is an AIM-listed investment company focused on backing high-growth, disruptive ventures within the life sciences and technology sectors, offering investors access to opportunities often beyond the reach of the general public.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Leave a Reply